677
Views
5
CrossRef citations to date
0
Altmetric
Gastroenterology

The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study

, , , , &
Pages 541-551 | Received 12 Oct 2021, Accepted 15 Feb 2022, Published online: 04 Mar 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Maryia Zhdanava, Zhijie Ding, Ameur M. Manceur, Ruizhi Zhao, Christopher Holiday, Sumesh Kachroo, James Izanec & Dominic Pilon. (2023) Long-term persistence and other treatment patterns among bio-naïve patients with Crohn’s disease treated with ustekinumab or adalimumab. Current Medical Research and Opinion 39:9, pages 1215-1225.
Read now
Nishaanth Dalavaye, Simon Erridge, Martha Nicholas, Manaswini Pillai, Lara Bapir, Carl Holvey, Ross Coomber, James J Rucker, Jonathan Hoare & Mikael H Sodergren. (2023) The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry. Expert Review of Gastroenterology & Hepatology 17:1, pages 85-98.
Read now

Articles from other publishers (3)

Sabree C Burbage, Kathryn L Krupsky, M Janelle Cambron-Mellott, Nate Way, Aarti A Patel & Julia J Liu. (2024) Racial and Ethnic Disparities in Health-Related Outcomes in Crohn’s Disease: Results From the National Health and Wellness Survey. Crohn's & Colitis 360 6:2.
Crossref
Olivia Kahn-BoeselSandhya CauthaNneka N. UfereAshwin N. AnanthakrishnanBharati Kochar. (2023) A Narrative Review of Financial Burden, Distress, and Toxicity of Inflammatory Bowel Diseases in the United States. American Journal of Gastroenterology 118:9, pages 1545-1553.
Crossref
Cindy C Y Law, Bryce Tkachuk, Stephen Lieto, Neeraj Narula, Samantha Walsh, Jean-Frédéric Colombel & Ryan C Ungaro. (2023) Early Biologic Treatment Decreases Risk of Surgery in Crohn’s Disease but not in Ulcerative Colitis: Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.